EMEA-003070-PIP01-21

Key facts

Active substance
  • Ramipril
  • amlodipine (as besylate)
Therapeutic area
Cardiovascular diseases
Decision number
P/0513/2021
PIP number
EMEA-003070-PIP01-21
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of hypertension
Route(s) of administration
Oral use
Contact for public enquiries
1A Pharma GmbH

Email: enquiries.paediatrics@sandoz.com 
Tel. +31 365241710

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating